Recursion Pharmaceuticals Ownership | Who Owns Recursion Pharmaceuticals?
Recursion Pharmaceuticals Ownership Summary
Recursion Pharmaceuticals is owned by 92.31% institutional investors, 4.52% insiders, and 3.16% retail investors. Ark investment management is the largest institutional shareholder, holding 11.92% of RXRX shares. Scottish Mortgage Ord is the top mutual fund, with 6.44% of its assets in Recursion Pharmaceuticals shares.
RXRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Recursion Pharmaceuticals | 92.31% | 4.52% | 3.16% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ark investment management | 28.14M | 11.92% | $211.07M |
| Baillie gifford | 26.59M | 11.27% | $199.42M |
| Vanguard group | 21.56M | 9.13% | $161.67M |
| Blackrock | 17.31M | 7.33% | $129.83M |
| Ra capital management | 15.38M | 6.52% | $115.38M |
| Mubadala investment co pjsc | 12.99M | 5.50% | $97.39M |
| Kinnevik ab (publ) | 11.91M | 5.04% | $89.29M |
| Sumitomo mitsui trust | 9.99M | 4.23% | $74.90M |
| Nikko asset management americas | 9.93M | 4.21% | $74.31M |
| State street | 8.75M | 3.71% | $65.62M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Kinnevik ab (publ) | 11.91M | 100.00% | $89.29M |
| Dcvc opportunity fund ii gp | 3.95M | 44.95% | $29.63M |
| Data collective iv gp | 5.94M | 31.23% | $44.56M |
| Nvidia | 7.71M | 14.70% | $57.80M |
| Mic capital management uk llp | 8.45M | 13.78% | $63.39M |
| Ark investment management | 28.14M | 1.87% | $211.07M |
| Ra capital management | 15.38M | 1.53% | $115.38M |
| Commons capital | 111.11K | 1.00% | $833.30K |
| Exor capital llp | 3.68M | 0.93% | $27.56M |
| Nikko asset management americas | 9.93M | 0.86% | $74.31M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | 15.38M | 1.53% | 15.38M |
| Vanguard group | 21.56M | 0.00% | 5.54M |
| Blackrock | 17.31M | 0.00% | 4.99M |
| Ark investment management | 28.14M | 1.87% | 3.56M |
| Baillie gifford | 26.59M | 0.16% | 2.52M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Laurion capital management lp | - | - | -2.90M |
| State street | 8.75M | 0.00% | -1.60M |
| Platinum investment management | 395.67K | 0.12% | -1.40M |
| Ghisallo capital management | - | - | -1.10M |
| Fmr | 8.19M | 0.00% | -1.07M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ra capital management | 15.38M | 1.53% | 15.38M | $115.38M |
| Norges bank | 1.95M | 0.00% | 1.95M | $14.60M |
| Woodline partners lp | 664.45K | 0.05% | 664.45K | $4.98M |
| Neuberger berman group | 355.64K | 0.00% | 355.64K | $2.67M |
| Scientech research | 140.29K | 0.22% | 140.29K | $1.05M |
Sold Out
| Holder | Change |
|---|---|
| Financial gravity asset management | -4.00 |
| Householder group estate & retirement specialist | -11.00 |
| Gradient investments | -15.00 |
| Corecap advisors | -26.00 |
| Nelson, van denburg & campbell wealth management group | -28.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 275 | -1.43% | 260,863,978 | 3.59% | 92 | 0.81% | 154 | -13.97% | 49 | - |
| Jun 30, 2024 | 277 | 8.20% | 251,804,695 | 20.07% | 106 | 1.35% | 177 | 12.74% | 49 | -5.77% |
| Mar 31, 2024 | 256 | 25.49% | 209,712,724 | 1.55% | 88 | 1.13% | 157 | 38.94% | 52 | 15.56% |
| Dec 31, 2023 | 204 | 2.00% | 206,519,352 | 35.69% | 88 | 1.76% | 113 | -14.39% | 45 | 25.00% |
| Sep 30, 2023 | 200 | 25.79% | 152,197,134 | 19.37% | 71 | 1.77% | 132 | 57.14% | 36 | -14.29% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Scottish Mortgage Ord | 18.17M | 6.44% | - |
| ARK Disruptive Innovation Full Composite | 17.83M | 6.32% | 1.17M |
| ARK Innovation ETF | 18.40M | 6.31% | 331.00K |
| ARK Genomic Revolution | 12.71M | 4.50% | 3.20M |
| ARK Genomic Revolution ETF | 13.09M | 4.49% | 63.02K |
| Vanguard Total Stock Mkt Idx Inv | 8.03M | 2.80% | 13.30K |
| SPDR® S&P Biotech ETF | 7.45M | 2.56% | 82.47K |
| Vanguard Small Cap Index | 6.22M | 2.17% | 12.15K |
| iShares Russell 2000 ETF | 6.12M | 2.14% | -13.76K |
| Nikko AM ARK Disruptive Innovation A USD | 4.88M | 1.68% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 05, 2024 | Gibson Christopher | Chief Executive Officer | Sell | $142.40K |
| Dec 04, 2024 | Gibson Christopher | Chief Executive Officer | Sell | $143.20K |
| Nov 14, 2024 | Gibson Christopher | Chief Executive Officer | Sell | $147.00K |
| Nov 13, 2024 | Gibson Christopher | Chief Executive Officer | Sell | $154.80K |
| Nov 12, 2024 | Borgeson Blake | - | Sell | $87.46K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 15 |
| 2024 Q3 | - | 21 |
| 2024 Q2 | - | 22 |
| 2024 Q1 | - | 33 |
| 2023 Q4 | - | 27 |
RXRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools